1. Home
  2. MUX vs EVO Comparison

MUX vs EVO Comparison

Compare MUX & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo McEwen Mining Inc.

MUX

McEwen Mining Inc.

HOLD

Current Price

$18.61

Market Cap

1.1B

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.11

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MUX
EVO
Founded
1979
1993
Country
Canada
Germany
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MUX
EVO
Price
$18.61
$3.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$21.63
$7.00
AVG Volume (30 Days)
1.2M
250.1K
Earning Date
11-06-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$166,453,000.00
$887,396,457.00
Revenue This Year
$3.15
N/A
Revenue Next Year
$43.83
$8.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.38
$2.84
52 Week High
$24.88
$4.80

Technical Indicators

Market Signals
Indicator
MUX
EVO
Relative Strength Index (RSI) 48.13 48.75
Support Level $19.05 $3.03
Resistance Level $20.22 $3.18
Average True Range (ATR) 1.03 0.08
MACD -0.10 0.03
Stochastic Oscillator 14.11 72.58

Price Performance

Historical Comparison
MUX
EVO

About MUX McEwen Mining Inc.

McEwen Inc, formerly McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, majority of production occurs in the United States.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: